<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02289235</url>
  </required_header>
  <id_info>
    <org_study_id>CT-P-9364-6254</org_study_id>
    <nct_id>NCT02289235</nct_id>
  </id_info>
  <brief_title>The Effects of Ginger on Nonalcoholic Fatty Liver Disease</brief_title>
  <acronym>GinLiv</acronym>
  <official_title>The Effects of Ginger on Biochemical Markers and Imaging Studies of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shiraz University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shiraz University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to evaluate the effects and safety of ginger in treatment of
      nonalcoholic fatty liver disease (NAFLD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ginger (Zingiber officinale Roscoe) has been cultivated for medicinal and culinary purposes
      for at least two millennia. It contains several hundred valuable compounds and new
      constituents are still being found. Ginger's high antioxidant value has proved highly
      effective with its ability to scavenge a number of free radicals and protect cell membrane
      lipids from oxidation in a dose-dependent manner.

      In a randomized double-blind placebo-controlled clinical trial, the investigators want to
      investigate the effects of ginger in treatment of nonalcoholic fatty liver disease (NAFLD).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ALT (liver transaminases) level</measure>
    <time_frame>Baseline and 3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in grade of fatty liver in sonography by use of Saverymuttu Scoring System</measure>
    <time_frame>Baseline and 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in AST (liver transaminases) level</measure>
    <time_frame>Baseline and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Gama GT (Î³-glutamyl transpeptidase) levels</measure>
    <time_frame>Baseline and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Fatty Liver</condition>
  <arm_group>
    <arm_group_label>Ginger</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ginger powder capsule 500 mg daily for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo powder 1 capsule daily for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ginger</intervention_name>
    <description>Ginger powder capsule 500 mg daily for 3 months</description>
    <arm_group_label>Ginger</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo powder 1 capsule daily for 3 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 20-65 years

          -  Body mass index: 18-35 kg/m2

          -  Serum ALT level: &gt;60 U/Lit. in males, &gt;38 U/Lit. in females

          -  Grade &gt;=2 fatty liver in liver sonography

        Exclusion Criteria:

          -  Pregnancy

          -  Acute or chronic liver failure

          -  Acute or chronic renal failure

          -  Autoimmune or viral hepatitis

          -  Wilson's disease

          -  Diabetes mellitus

          -  Alcoholism

          -  Malignancy

          -  Hypothyroidism or hyperthyroidism

          -  Drug used in last three months: OCP, metformin, vitamin E, ursodeoxycholic acid,
             glucocorticoids, thiazolidenediones.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mesbah Shams, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Majid Nimruzi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Traditional Medicine &amp; History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kamran Bagheri Lankarani, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Health policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>MohammadAli Nejati, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gastroenterology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amin Abulhasani Foroughi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shahid Motahhari Clinic, Shiraz University of Medical Sciences</name>
      <address>
        <city>Shiraz</city>
        <state>Fars</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2014</study_first_submitted>
  <study_first_submitted_qc>November 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2014</study_first_posted>
  <last_update_submitted>February 22, 2016</last_update_submitted>
  <last_update_submitted_qc>February 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shiraz University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Mesbah Shams, MD</investigator_full_name>
    <investigator_title>Associate professor of Internal Medicine &amp; Endocrinology</investigator_title>
  </responsible_party>
  <keyword>Ginger</keyword>
  <keyword>Medicine, traditional</keyword>
  <keyword>Herbal medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

